SCHEMBL409546

SCHEMBL409546

COCCOCC(COCCOC)(COCCOC)COCCOC

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.33
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15199305 0.97 THRB (0.32) THRBCA2
SCHEMBL14838352 0.94 THRB (0.31) THRBCA2
SCHEMBL17936174 0.94 THRB (0.31) THRBCA2
SCHEMBL13524892 0.89 THRB (0.33) THRB
SCHEMBL10138602 0.87 THRB (0.32) THRBCA2
SCHEMBL27262180 0.86 THRB (0.47) THRB
SCHEMBL16021743 0.85
SCHEMBL19655509 0.84 THRB (0.46) THRBCA2
SCHEMBL16021812 0.83
SCHEMBL13085159 0.83 THRB (0.38) THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-59082328-A None JP disclosed
US-20180194955-A1 PHOTO CURABLE INK COMPOSITION HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2018-07-12 US disclosed
US-20180112037-A1 POLYMERIC AMINE SYNERGIST HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2018-04-26 US disclosed
US-20180072845-A1 POLYMERIC AMINE SYNERGIST COMPOSITIONS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2018-03-15 US disclosed
US-20180009945-A1 POLYMERIC PHOTOACTIVE AGENTS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2018-01-11 US disclosed
US-20170355864-A1 POLYMERIC PHOTOACTIVE AGENT COMPOSITIONS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2017-12-14 US disclosed
US-20130213894-A1 CLEANING METHOD OF IMMERSION LIQUID, IMMERSION LIQUID CLEANING COMPOSITION, AND SUBSTRATE JSR CORPORATION (JP) 2013-08-22 US disclosed
US-20130081999-A1 Bridged Macrocyclic Module Compositions WHITEFORD JEFFERY A (US) 2013-04-04 US disclosed
US-20130081999-A1 Bridged Macrocyclic Module Compositions WHITEFORD JEFFERY A (US) 2013-04-04 US disclosed
US-8182695-B2 Bridged macrocyclic module compositions WHITEFORD JEFFERY A (US) 2012-05-22 US disclosed
US-8182695-B2 Bridged macrocyclic module compositions WHITEFORD JEFFERY A (US) 2012-05-22 US disclosed
US-20120064061-A1 ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF INNOTHERAPY INC. (KR) 2012-03-15 US disclosed
US-20080290034-A1 Bridged macrocyclic module compositions COVALENT PARTNERS LLC 2008-11-27 US disclosed
US-20080290034-A1 Bridged macrocyclic module compositions COVALENT PARTNERS LLC 2008-11-27 US disclosed
US-7368564-B2 Bridged macrocyclic module compositions COVALENT PARTNERS, LLC (US) 2008-05-06 US disclosed
US-7368564-B2 Bridged macrocyclic module compositions COVALENT PARTNERS, LLC (US) 2008-05-06 US disclosed
JP-S5982328-A NOVEL ETHER COMPOUND AND ITS PREPARATION CHISSO CORP 1984-05-12 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180112037-A1 POLYMERIC AMINE SYNERGIST PNMT, TYR, DOT1L THRB 4488/4885CA2 4783/4885
US-20120064061-A1 ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF EPCAM, ICAM1, VCAM1 THRB 2089/4885CA2 4427/4885
US-20130081999-A1 Bridged Macrocyclic Module Compositions SBDS, NCL, INTS6 THRB 4871/4885CA2 4614/4885
US-20080290034-A1 Bridged macrocyclic module compositions SBDS, NCL, INTS6 THRB 4874/4885CA2 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.